Early Stage Biomedical Articles & Analysis
2 news found
Following the successful completion of the R&D project in 30th September 2016 (supported by a Smart award from the Innovate UK (TSB), Arterius has recently been awarded further funding from the Biomedical Catalyst-Early Stage programme to conduct the In-vitro and In-vivo GLP Evaluation of the Novel Bioresorbable Coronary Scaffolds; ...
P-21 is safe, as no liability issues were observed in vitro, in multiple cell based assays or in the vivo animal model. About Shifa Biomedical Corp. Shifa Biomedical Corporation (Shifa) is a drug discovery company in Malvern Pennsylvania. ...